Skip to search formSkip to main contentSkip to account menu

cytarabine/etoposide

Known as: ARA-C/VP-16 
A combination of agents containing cytarabine and etoposide.
National Institutes of Health

Related topics

Related topics

2 relations
CytarabineEtoposide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
Attempts to optimize induction and consolidation treatment in acute myeloid leukemia: results of the MRC AML12 trial.
PURPOSE To optimize treatment for younger patients with acute myeloid leukemia and high-risk myelodysplastic syndrome by… 
2010
2010
Cytarabine/etoposide/ibritumomab tiuxetan Y-90
  • 2010
  • Corpus ID: 265698171
2010
2010
High-dose of daunorubicin as induction treatment for adults with newly diagnosed Philadelphia-negative acute lymphoblastic leukemia.
6589 Background: Although daunorubicin (D) has been used as major part of induction treatment for adult acute lymphoblastic… 
2007
2007
Treatment of primary CNS lymphoma with induction high-dose methotrexate, temozolomide, rituximab followed by consolidation cytarabine/etoposide: A pilot study with biomarker analysis.
7595 Background: There is currently no consensus on the optimal treatment for patients diagnosed with primary CNS lymphoma (PCNSL… 
2006
2006
Treatment of primary CNS lymphoma with induction high-dose methotrexate, temozolomide, rituximab followed by consolidation cytarabine/etoposide: A pilot study with biomarker analysis
7595 Background: There is currently no consensus on the optimal treatment for patients diagnosed with primary CNS lymphoma (PCNSL… 
2006
2006
Cytarabine/etoposide/granulocyte colony-stimulating factors
  • 2006
  • Corpus ID: 195108447
2005
2005
Low dose involved field radiation (IFRT) or no further treatment following complete response to initial chemotherapy in young adult (YA) patients 16–21 years of age with Hodgkin’s disease (HD): The…
8513 Background: There is scant data in the literature concerning the outcome of YA pts 16–21 years of age with HD. Methods… 
Highly Cited
2002
Highly Cited
2002
Intensified and shortened cyclical chemotherapy for adult acute lymphoblastic leukemia.
PURPOSE To assess the efficacy and toxicity of a new treatment program of intensified and shortened cyclical chemotherapy… 
Highly Cited
1999
Highly Cited
1999
Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.
In study NHL-BFM 90, we investigated whether the serum lactate dehydrogenase (LDH) concentration and early response are useful… 
Highly Cited
1995
Highly Cited
1995
Invasive fungal disease in adults undergoing remission-induction therapy for acute myeloid leukemia: the pathogenetic role of the antileukemic regimen.
Using multivariate techniques, we studied the relationships of cytotoxic regimen, intestinal mucosal damage, and fungal… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)